Search results
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 1 day agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
Combined flu and Covid vaccine from Moderna shows positive results
dpa international via Yahoo News· 3 days agoThe results raise hopes the new vaccine could be approved by regulators this year, with the...
New RSV shots tied to rare nervous system disorder — should you worry?
LiveScience· 3 hours agoThe new RSV vaccines approved for older adults may be linked to a slightly increased risk of a rare...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 4 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 3 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 3 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 5 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long ...